The Biological Response of Human NP Cells to Soluble Collagen VI
Cells · 26.07.2026 · 15 (15) · 1339
DOI: 10.3390/cells15151339 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 26.07.2026. Verfasst von Jonathan Dalton und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, Thomas Jefferson University, Philadelphia, PA 19107, USA. Hauptthemen laut MEDLINE: Collagen Type VI, Nucleus Pulposus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Rothman Institute.
Abstract (Originalsprache)
Extracellular matrix (ECM) dysregulation plays a significant role in the development of intervertebral disc disease (IVDD). The ECM around the chondrocytes in the nucleus pulposus (NP) is unique in that it contains ColVI. While linked to chondrocyte proliferation in cartilage, ColVI’s specific role in IVD degeneration is less clear. Our aim was to determine the expression of ColVI in NP cells from degenerative IVDs, along with the effects of soluble ColVI on NP cells. Thus, we compared the expression levels of ColVI in human degenerated IVD samples, along with the effect of soluble ColVI on primary human NP cells. A higher Pfirrmann grade was associated with increased COL6A1 mRNA expression, with a 4.4-fold increase in Pfirrmann grade IV (p = 0.024) and a 5.3-fold increase in grade V compared to grade III (p = 0.014). Soluble ColVI increased NP cell proliferation compared to untreated controls, from 1.204-fold for 5 µg/mL (p < 0.001) and 1.335-fold for 10 µg/mL (p = 0.001). The most upregulated gene was IGF-1 (7.9-fold increase). Co-treatment of NP cells with ColVI and an ERK inhibitor showed significantly less IGF-1 mRNA upregulation compared to ColVI treatment alone (6.2-fold vs. 12.4-fold; p = 0.009). Our findings suggest that degenerating discs are associated with COL6A1 upregulation by NP cells; moreover, the addition of soluble ColVI to NP cells increases NP cell proliferation and IGF-1 expression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, Thomas Jefferson University, Philadelphia, PA 19107, USA.
- Department of Orthopaedic Surgery, Rothman Institute, Philadelphia, PA 19107, USA.
- Department of Orthopedic Surgery, Northwestern Hospital, Chicago, IL 60611, USA.
- Department of Orthopedic Surgery, Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
ORCID-Profile: Panya Luksanapruksa, Mitchell K Ng, Rachel Huang, Alan S Hilibrand, Alexander R Vaccaro, Dessislava Z Markova
Förderung
- The Rothman Institute
Zitieren
APA
Dalton, J., Divi, S. N., Eichbaum, Y. K., Luksanapruksa, P., Ng, M. K., Huang, R., Hilibrand, A. S., Vaccaro, A. R., Markova, D. Z., & Kepler, C. K. (2026). The Biological Response of Human NP Cells to Soluble Collagen VI. Cells, 15(15), 1339. https://doi.org/10.3390/cells15151339
Vancouver
Dalton J, Divi SN, Eichbaum YK, Luksanapruksa P, Ng MK, Huang R, et al. The Biological Response of Human NP Cells to Soluble Collagen VI. Cells. 2026;15(15):1339. doi:10.3390/cells15151339
BibTeX
@article{Dalton2026,
author = {Dalton, Jonathan and Divi, Srikanth N and Eichbaum, Yasmine K and Luksanapruksa, Panya and Ng, Mitchell K and Huang, Rachel and Hilibrand, Alan S and Vaccaro, Alexander R and Markova, Dessislava Z and Kepler, Christopher K},
title = {The Biological Response of Human NP Cells to Soluble Collagen VI},
journal = {Cells},
year = {2026},
volume = {15},
number = {15},
pages = {1339},
doi = {10.3390/cells15151339}
}
EUVIMED